/
JAGX
$0.78+$0.02 (+3.04%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$3.7M
5M shares
52-week range
$0.73 – $77.63
0% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-12456820.47
Jaguar Health, Inc.
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
www.jaguar.health- Employees
- 47
- IPO / List date
- May 13, 2015
- HQ
- SAN FRANCISCO, CA
Held by traders on TradeandTell
No one on the platform currently holds JAGX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in JAGX as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-04-30 | 1-for-35reverse |
| 2026-03-02 | 1.1-for-1 |
| 2025-03-24 | 1-for-25reverse |
| 2024-05-23 | 1-for-60reverse |
| 2023-01-23 | 1-for-75reverse |
Recent trades on TradeandTell
No one on the platform has traded JAGX yet.
